Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial

Authors

Institutions

Publication Details

Journal
BMC Pulmonary Medicine
Published
2025-04-09
DOI
https://doi.org/10.1186/s12890-025-03629-6
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial

Niloofar Khoshnam Rad, Hamidreza Abtahi, Shahideh Amini, Mehrdad Mokri et al.
BMC Pulmonary Medicine
Asthma and respiratory diseases
article

Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial

Niloofar Khoshnam Rad, Hamidreza Abtahi, Shahideh Amini, Mehrdad Mokri, Marsa Gholamzadeh, Ghazal Roostaei, Besharat Rahimi
article en

Abstract

No abstract available for this paper.
BMC Pulmonary MedicineVol. 25(1)
Uppsala University (SE), Imam Khomeini Hospital (IR), Shaheed Rajaei Cardiovascular Medical and Research Center (IR), Tehran University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 91%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.